REQUEST A DEMO
Total
USD $0.00
Search more companies

Eli Lilly Cr, S.R.O. (Czech Republic)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Eli Lilly Cr, S.R.O. Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Eli Lilly Cr, S.R.O. is an enterprise in Czech Republic, with the main office in Prague. The company operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was first established on December 19, 1995. 50 - 99 (2024) employees currently work for Eli Lilly Cr, S.R.O.. From the latest financial highlights, Eli Lilly Cr, S.R.O. reported a net sales revenue increase of 6.87% in 2022. Its’ total assets recorded a growth of 30.82%. Eli Lilly Cr, S.R.O.’s net profit margin increased by 1.8% in 2022.

Headquarters
Pobrezni 394/12
Prague; The City of Prague; Postal Code: 18600

Contact Details: Purchase the Eli Lilly Cr, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Eli Lilly Cr, S.R.O. report to view the information.
Outstanding Shares:
Purchase the Eli Lilly Cr, S.R.O. report to view the information.
Registered Capital:
Purchase the Eli Lilly Cr, S.R.O. report to view the information.
Incorporation Date:
December 19, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Eli Lilly Cr, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
6.87%
Total operating revenue
7.3%
Operating profit (EBIT)
6.92%
EBITDA
49.17%
Net Profit (Loss) for the Period
38.54%
Total assets
30.82%
Total equity
7.65%
Operating Profit Margin (ROS)
0%
Net Profit Margin
1.8%
Return on Equity (ROE)
2.43%
Quick Ratio
-1.42%
Cash Ratio
-0.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?